This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLinked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkEN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLinked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkEN - EnglishSelect a languageLanguagesEN - EnglishFR - FrançiasSearch

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Menu

Close

Vaccinating with TicoVac and TicoVac JuniorSupport & ResourcesSupport & ResourcesVideosMaterials
Click here for TicoVac (Tick - Borne Encephalitis Vaccine (whole Virus, inactivated)) Prescribing Information. Adverse event reporting information can be found at the bottom of the page. 
TicoVac® (Tick-Borne Encephalitis Vaccine (whole Virus inactivated))Focus on Tick-Borne Encephalitis  (TBE)Help protect people from TBE with TicoVac and TicoVac Junior1,2

TBE is a rare viral infection of the central nervous system, that affects the brain and spinal cord.3,4 Transmission to humans most commonly occurs through one bite of an infected tick.5

TBE can be serious

TBE is a serious infection that can appear in two stages.

  • The first stage of flu-like symptoms occurs between 2 days and 4 weeks after being bitten by an infected tick.4,6
  • In some people second-stage symptoms occur due to the virus spreading to the central nervous system and causing meningitis or encephalitis.4,6
There is no specific treatment for TBE. Most patients with TBE will recover, but up to one third will suffer long-term complications of the disease.7The following activities (below), whether they be for leisure or work purposes, could result in people being more likely to come into contact with ticks:6,7The invisible risk​​​​​​

Ticks carrying the TBE virus are usually active from early spring to late autumn and are generally found close to the ground in forested or grassy areas, including parks and gardens, as well as meadows.6

TBE endemic countries

You may know that ticks can transmit Lyme disease,7 but are you aware that in certain parts of Europe and Asia, they can also carry TBE?3 Vaccination can help to prevent TBE and  should be considered when travelling to the following countries:3,5,8,9

Europe
  • Albania
  • Austria
  • Belarus
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Moldova
  • Montenegro
  • Netherlands
  • Norway
  • Poland
  • Romania
  • Russia
  • Serbia
  • Slovakia
  • Slovenia
  • Sweden
  • Switzerland
  • Ukraine
Asia
  • China
  • Kazakhstan
  • Mongolia

References

TicoVac Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/1923  (Last accessed: March 2023)TicoVac Junior Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/1927 (Last accessed: March 2023)Factsheet about tick-borne encephalitis (TBE). European Centre for Disease Prevention and Control. Available at: https://www.ecdc.europa.eu/en/tick-borne-encephalitis/facts/factsheet (Last accessed: March 2023)Haglund M. and Gunther G. Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up. Vaccine. 2003;21 Suppl 1:S11-8  Lindquist L. and Vapalahti O. Tick-borne encephalitis. Lancet. 2008;371(9627):1861-71.Travel Health Pro. TBE factsheet. Available at: http://travelhealthpro.org.uk/factsheet/22/tick-borne-encephalitis. (Last accessed: March 2023)World Health Organisation Regional Office for Europe. Tick-borne encephalitis in Europe. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/healthtopics/vectors/world-health-day-2014/Documents/factsheet-tick-borne-encephalitis.pdf. (Last accessed: March 2023)WHO. Health Topics: Tick-borne encephalitis overview. Available at: https://www.who.int/health-topics/tick-borne-encephalitis#tab=tab_1 (Last accessed: March 2023)WHO. Health Topics: Tick-borne encephalitis prevention. Available at: https://www.who.int/health-topics/tick-borne-encephalitis#tab=tab_3 (Last accessed: March 2023)
PP-TCV-GBR-0162. March 2023

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store


Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2023 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-4885. May 2023
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

YesNo
You are now leaving PfizerPro​​​​​
​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​